"Available resources include research nursing, nutrition, informatics, statistics, regulatory and compliance support and core laboratory services. All services are provided as fee-for-service resources. Only IRB-approved protocols can request CTRC services."

During the past decade, University of Colorado Denver CTO (CTRC) conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 12 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado Denver CTO (CTRC)" #1 collaborator was "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado Denver CTO (CTRC)" are "Advanced Cancer" (2 trials), "Alopecia Areata" (2 trials), "Advanced Cancers" (1 trials), "Arterial Dysfunction" (1 trials) and "Autonomic Dysfunction" (1 trials). Many other conditions were trialed in "University of Colorado Denver CTO (CTRC)" in a lesser frequency.

Most popular intervention types in "University of Colorado Denver CTO (CTRC)" are "Drug" (17 trials), "Biological" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (3 trials), "Binimetinib" (3 trials), "Docetaxel" (2 trials), "Encorafenib" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado Denver CTO (CTRC)" are 17 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Colorado Denver CTO (CTRC)". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Colorado Denver CTO (CTRC), undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado Denver CTO (CTRC), 7 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".